FDA Inspection 703131 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3005622193

The FDA completed an inspection of Biomat USA, Inc. on December 23, 2010 in San Antonio, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 23, 2010
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Antonio, TX (United States)

Citations

IDCFRDescription
324821 CFR 640.63(a)Determining donor suitability
922521 CFR 606.171Biological product deviation report
9821 CFR 606.100(c)Thorough investigations